BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 53266)

  • 1. Cell-mediated lympholysis of N-(3-nitro-4-hydroxy-5-iodophenylacetyl)-beta-anaylglycylglycyl-modified autologous lymphocytes. Effector cell specificity to modified cell surface components controlled by the H-2K and H-2D serological regions of the murine major histocompatibility complex.
    Rehn TG; Shearer GM; Koren HS; Inman JK
    J Exp Med; 1976 Jan; 143(1):127-42. PubMed ID: 53266
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cell-mediated lympholysis of trinitrophenyl-modified autologous lymphocytes. Effector cell specificity to modified cell surface components controlled by H-2K and H-2D serological regions of the murine major histocompatibility complex.
    Shearer GM; Rehn TG; Garbarino CA
    J Exp Med; 1975 Jun; 141(6):1348-64. PubMed ID: 47900
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cell-mediated lympholysis of trinitrophenyl-modified autologous lymphocytes. Confirmation of genetic control of response to trinitrophenyl-modified H-2 antigens by the use of anti-H-2 and anti-Ia antibodies.
    Schmitt-Verhulst AM; Sachs DH; Shearer GM
    J Exp Med; 1976 Jan; 143(1):211-7. PubMed ID: 1244419
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Multiple H-2 linked immune response gene control of H-2 D-associated T-cell-mediated lympholysis to trinitrophenyl-modified autologous cells: Ir-like genes mapping to the left of I-A and within the I region.
    Schmitt-Verhulst AM; Shearer GM
    J Exp Med; 1976 Dec; 144(6):1701-6. PubMed ID: 1087329
    [TBL] [Abstract][Full Text] [Related]  

  • 5. H-2-linked genetic control of murine T-cell-mediated lympholysis to autologous cells modified with low concentrations of trinitrobenzene sulfonate.
    Shearer GM; Schmitt-Verhulst AM; Pettinelli CB; Miller MW; Gilheany PE
    J Exp Med; 1979 Jun; 149(6):1407-23. PubMed ID: 109569
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bifunctional major histocompatibility-linked genetic regulation of cell-mediated lympholysis to trinitrophenyl-modified autologous lymphocytes.
    Schmitt-Verhulst AM; Shearer GM
    J Exp Med; 1975 Oct; 142(4):914-27. PubMed ID: 52685
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mixed lymphocyte reactivity and cell-mediated lympholysis to trinitrophenyl-modified autologous lymphocytes in C57BL/10 congenic and B10-A recombinant mouse strains.
    Shearer GM; Lozner EC; Rehn TG; Schmitt-Verhulst AM
    J Exp Med; 1975 Apr; 141(4):930-4. PubMed ID: 123935
    [TBL] [Abstract][Full Text] [Related]  

  • 8. On the role of the H-2 histocompatibility complex in determining the specificity of cytotoxic effector cells sensitized against syngeneic trinitrophenyl-modified targets.
    Forman J
    J Exp Med; 1975 Aug; 142(2):403-18. PubMed ID: 1079848
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Regulation of T-cell-mediated lympholysis by the murine major histocompatibility complex. I. Preferential in vitro responses to trinitrophenyl-modified self K- and D-coded gene products in parental and F1 hybrid mouse strains.
    Levy RB; Shearer GM
    J Exp Med; 1979 Jun; 149(6):1379-92. PubMed ID: 109568
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cell-mediated lympholysis to H-2-matched target cells modified with a series of nitrophenyl compounds.
    Rehn TG; Inman JK; Shearer GM
    J Exp Med; 1976 Oct; 144(4):1134-40. PubMed ID: 62013
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cytotoxic T lymphocytes specific for I region determinants do not require interactions with H-2K or D gene products.
    Billings P; Burakoff S; Dorf ME; Benacerraf B
    J Exp Med; 1977 May; 145(5):1387-92. PubMed ID: 67179
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Alloantigen-activated lysis of syngenic tumor augmented by allogenic lymphocytes as cold targets.
    Sugarbaker PH; Matthews W
    Oncology; 1985; 42(6):377-83. PubMed ID: 2933618
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Induction and characterization of minor histocompatibility antigens. Specific primary cytotoxic T lymphocyte responses in vitro.
    Ando K; Nakashima I; Nagase F; Isobe K; Kawashima K; Hasegawa Y; Yoshida T; Iwamoto T; Hasegawa T; Muro Y
    J Immunol; 1988 Feb; 140(3):723-9. PubMed ID: 2448374
    [TBL] [Abstract][Full Text] [Related]  

  • 14. H-2 homology requirements for secondary cell-mediated lympholysis and miced lymphocyte reactions to TNP-modified syngeneic lymphocytes.
    Schmitt-Verhulst AM; Garbarino CA; Shearer GM
    J Immunol; 1977 Apr; 118(4):1420-7. PubMed ID: 66294
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Specificity of cytotoxic effector cells directed against trinitrobenzene sulfonate-modified syngeneic cells. Failure to recognize cell surface-bound trinitrophenyl dextran.
    Henkart PA; Schmitt-Verhulst M; Shearer GM
    J Exp Med; 1977 Oct; 146(4):1068-78. PubMed ID: 70501
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The major histocompatibility complex determines susceptibility to cytotoxic T cells directed against minor histocompatibility antigens.
    Bevan MJ
    J Exp Med; 1975 Dec; 142(6):1349-64. PubMed ID: 53263
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cell-mediated lympholysis. Importance of serologically defined H-2 regions.
    Alter BJ; Schendel DJ; Bach ML; Bach FH; Klein J; Stimpfling JH
    J Exp Med; 1973 May; 137(5):1303-9. PubMed ID: 4267208
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mixed lymphocyte reactivity and cell-mediated lympholysis to D-end differences of the murine major histocompatibility complex. Comparison of in vitro responses to exclusive D-end or more extensive MHC differences.
    Hodes RJ; Schmitt-Verhulst AM; Hathcock KS; Shearer GM
    Scand J Immunol; 1976; 5(4):369-82. PubMed ID: 133452
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Modulation of F1 cytotoxic potentials by graft-vs-host reaction. Cooperative non-H-2- and H-2D region-gene control of F1 natural resistance to graft-vs-host reaction-associated immunosuppression.
    Ishikawa H; Saito K; Kubota E
    J Immunol; 1989 Mar; 142(5):1495-9. PubMed ID: 2918225
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of sodium periodate modification of lymphocytes on the sensitization and lytic phases of T cell-mediated lympholysis.
    Schmitt-Verhulst A; Shearer GM
    J Immunol; 1976 Apr; 116(4):947-58. PubMed ID: 56407
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.